Terapevticheskii arkhiv
Cure8 research brief
Why This Matters
Diagnosis between UC, Crohn’s disease, and unclassified IBD can change in a meaningful minority of patients over years. Awareness of common reasons for reclassification (segmental disease, strictures) helps guide monitoring and follow-up testing.
Who Should Pay Attention
Clinicians, gastroenterology teams, researchers, adult IBD patients (especially those with UC or IBDU)
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This retrospective single-center cohort study of 800 patients examined how often and why inflammatory bowel disease (IBD) diagnoses were later changed. Over a median follow-up, 17.6% of patients had their diagnosis revised, most commonly from ulcerative colitis or unclassified IBD to Crohn’s disease.
Segmental bowel involvement and development of strictures were cited as important reasons prompting reclassification; median time to revision was measured in years. The paper highlights that initial IBD labels—especially UC or IBDU—may change over time as new clinical, endoscopic, or morphological information appears.
For clinicians, the findings support documenting diagnostic reassessment and remaining alert for features (segmental disease, strictures) that suggest a different IBD subtype. For patients, this means an IBD diagnosis may evolve with further testing or disease progression; periodic re-evaluation can be clinically important.
The study does not test specific treatments or biomarkers to predict reclassification.
Keep In Mind
Retrospective single-center study using clinical and morphological data; median time to reclassification was measured in months to years. Structured content is based on the source abstract and not a full independent review.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationTerapevticheskii arkhiv
PublisherConsilium Medicum
AuthorsIgor G. Bakulin, Yulia A. Akishina
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedAug 18, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Causes of Chronic Diarrhea in Adults: A Retrospective Analytical Study at Damascus Hospital, Syria
The study suggests most adults with chronic diarrhea in this tertiary setting had organic/inflammatory disease and identifies accessible clinical and lab predictors that could help prioritize endoscopic evaluation.
Testing-Yield Mismatch in Inpatient Micronutrient Assessment in Inflammatory Bowel Disease: A Real-World Implementation-Gap Analysis
Micronutrient deficiencies are common in IBD and can worsen anemia, healing, and neurologic function. This study shows inpatient testing focuses on B12 while missing other commonly deficient nutrients (B1, B6, zinc),...
Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.
Distinguishing IBD from gastrointestinal tuberculosis is challenging in regions where GITB is common; histologic markers like basal plasmacytosis and eosinophilia on mucosal biopsy could help guide diagnosis when...